Research Topics
| C M BalchSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch
Johns Hopkins Medical Institutions, Baltimore, MD, USA
J Clin Oncol 19:3635-48. 2001..To revise the staging system for cutaneous melanoma under the auspices of the American Joint Committee on Cancer (AJCC)...- The new melanoma staging systemChristina J Kim
Department of Surgery, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, USA
Cancer Control 9:9-15. 2002..This system will provide more accurate and precise information regarding patient prognosis. Validation studies are needed to confirm the accuracy of this revised staging system... - New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Semin Surg Oncol 21:43-52. 2003.... - Predicting outcomes in metastatic melanomaCharles M Balch
Departments of Surgery, Oncology, and Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
J Clin Oncol 26:168-9. 2008 
Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United StatesKarl Y Bilimoria
Cancer Programs, American College of Surgeons, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
J Clin Oncol 27:1857-63. 2009..Guidelines recommend sentinel lymph node biopsy (SLNB) for patients with clinical stage IB/II melanomas, but not clinical stage IA melanoma. This study examines factors associated with SLNB use for clinically node-negative melanoma...- Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rateCharles M Balch
Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Surg Oncol 104:379-85. 2011..A clinical scoring system model and multivariate predictive tool under the auspices of the AJCC has led to a first-generation web-based predictive tool (www.melanomaprognosis.org)... - Sentinel node biopsy and standard of care for melanomaCharles M Balch
Departments of Surgery, Oncology, and Dermatology, Johns Hopkins Medical Center, Baltimore, Maryland, USA
J Am Acad Dermatol 60:872-5. 2009..The panel comprised a cross section of expert melanoma surgeons who have contributed data and leadership to investigations of SNB... 
Final version of 2009 AJCC melanoma staging and classificationCharles M Balch
Department of Surgery, Oncology and Dermatology, Johns Hopkins Medical Institutions, 600 N Wolfe St, Osler 624, Baltimore, MD, 21287, USA
J Clin Oncol 27:6199-206. 2009..To revise the staging system for cutaneous melanoma on the basis of data from an expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database...- Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastasesCharles M Balch
Department of Surgery, Johns Hopkins Medical Institutions, 600 N Wolfe St, Osler 624, Baltimore, MD 21287, USA
J Clin Oncol 28:2452-9. 2010..To determine the survival rates and independent predictors of survival using a contemporary international cohort of patients with stage III melanoma... - Surgeon distress as calibrated by hours worked and nights on callCharles M Balch
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
J Am Coll Surg 211:609-19. 2010..The relationships of working hours and nights on call per week with various parameters of distress among practicing surgeons have not been previously examined in detail... - Combating stress and burnout in surgical practice: a reviewCharles M Balch
Johns Hopkins Medical Institutions, Department of Surgery, 1515 Orleans St Cancer Research Building II, Room 507, Baltimore, MD 21231, USA
Adv Surg 44:29-47. 2010..To provide the best care for our patients, we need to be alert, interested in our work, and ready to provide for our patient's needs. Maintaining these values and healthy habits is the work of a lifetime... - Burnout and career satisfaction among surgical oncologists compared with other surgical specialtiesC M Balch
Johns Hopkins Department of Surgery, Baltimore, MD, USA
Ann Surg Oncol 18:16-25. 2011..Little is known regarding the rate of burnout, career satisfaction, and quality of life (QOL) among surgical oncologists compared with other surgical subspecialties... - Combating stress and burnout in surgical practice: a reviewCharles M Balch
Johns Hopkins Medical Institutions, Department of Surgery, 1515 Orleans Street Cancer Research Building II, Room 507, Baltimore, MD 21231, USA
Thorac Surg Clin 21:417-30. 2011..This article explores causes of surgeon burnout and reviews results from the American College of Surgeons Burnout Survey. Strategies for personal and professional growth, wellness and renewal are also discussed... - Sentinel lymph node biopsy for melanoma: controversy despite widespread agreementK M McMasters
Department of Surgery, University of Louisville, James Graham Brown Cancer Center, KY 40202, USA
J Clin Oncol 19:2851-5. 2001..Overall, the benefit of accurate nodal staging obtained by SLN biopsy far outweighs the risks and has important implications for patient management... - Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomasC M Balch
Johns Hopkins Medical Center, Baltimore, Maryland, USA
Ann Surg Oncol 8:101-8. 2001..The Intergroup Melanoma Surgical Trial began in 1983 to examine the optimal surgical margins of excision for primary melanomas of intermediate thickness (i.e., 1-4 mm). There is now a median 10-year follow-up... - Burnout and career satisfaction among American surgeonsTait D Shanafelt
Mayo Clinic, Johns Hopkins Medical Institutions, Johns Hopkins University, Baltimore, Maryland, USA
Ann Surg 250:463-71. 2009..To determine the incidence of burnout among American surgeons and evaluate personal and professional characteristics associated with surgeon burnout... - How pathologic staging informs the surgical management of primary cutaneous melanomaS Tsai
Department of Surgery, Division of Surgical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
G Ital Dermatol Venereol 145:187-93. 2010.... - Arnoldus Goudsmit, MD, PhD: chemotherapist, visionary, founder of the American Society of Clinical Oncology, 1909-2005Gretchen M Krueger
Editorial Rx Inc, Orange Park, FL, USA
J Clin Oncol 24:4033-6. 2006 - Melanoma in children and teenagers: an analysis of patients from the National Cancer Data BaseJulie R Lange
Department of Surgery, Johns Hopkins Medicine, Baltimore, MD, USA
J Clin Oncol 25:1363-8. 2007..This study examines the demographics, presentation, and outcomes of children and teenagers with melanoma using a US hospital-based oncology database... - Melanoma in children: heightened awareness of an uncommon but often curable malignancyJulie R Lange
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Pediatrics 115:802-3. 2005 - Screening for cutaneous melanomaJulie R Lange
Johns Hopkins Medicine, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA
Surg Oncol Clin N Am 14:799-811. 2005..Programs targeting persons of low socioeconomic status and targeting white men over the age of 50 could address groups known to beat especially high risk of melanoma mortality... - Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch
Johns Hopkins Medical Institutions, Baltimore, MD, USA
J Clin Oncol 19:3622-34. 2001..Thirteen cancer centers and cancer cooperative groups contributed staging and survival data from a total of 30,450 melanoma patients from their databases in order to validate this staging proposal... - The new melanoma staging systemCharles M Balch
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Semin Cutan Med Surg 22:42-54. 2003..Physicians managing melanoma should use this staging system in their clinical practice and in the conduct of melanoma clinical trials... - Lymph node biopsy results for desmoplastic malignant melanomaDeborah L Cummins
Department of Dermatology, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
Cutis 79:390-4. 2007..All others had negative results from histology and S100 stains. This study suggests that the frequency of positive SLNBs in DMM may be substantially lower than that of other melanomas... - Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteriaAnna M Voltura
Department of Surgery, Division of Surgical Oncology, Johns Hopkins University, Baltimore, MD 21287, USA
Ann Surg Oncol 15:3396-401. 2008..The cosmetic result and high patient satisfaction of nipple-sparing mastectomy (NSM) has prompted further evaluation of the oncologic safety of this procedure... - National assessment of melanoma care using formally developed quality indicatorsKarl Y Bilimoria
Department of Surgery, American College Surgeons, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 3211, USA
J Clin Oncol 27:5445-51. 2009..The objectives of this study were to formally develop valid quality indicators for melanoma and to assess hospital-level adherence with these measures in the United States...